Report Detail
COVID-19 Impact on Global Animal Biological Vaccine Market Insights, Forecast to 2026
- RnM4071511 |
- 22 June, 2020 |
- Global |
- 146 Pages |
- QYResearch |
- Pharma & Healthcare
Animal Biological Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Animal Biological Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Animal Biological Vaccine market is segmented into
Oral
Subcutaneous
Intramuscular
Others
Segment by Application, the Animal Biological Vaccine market is segmented into
Porcine
Poultry
Livestock
Companion Animals
Aquaculture
Regional and Country-level Analysis
The Animal Biological Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Animal Biological Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Animal Biological Vaccine Market Share Analysis
Animal Biological Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Animal Biological Vaccine business, the date to enter into the Animal Biological Vaccine market, Animal Biological Vaccine product introduction, recent developments, etc.
The major vendors covered:
Merck
Zoetis
Merial/Sanofi
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco/Eli Lilly
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken
FATRO
Vaksindo
Bio-Labs
Avimex Animal
1 Study Coverage
- 1.1 Animal Biological Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Animal Biological Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Animal Biological Vaccine Market Size Growth Rate by Type
- 1.4.2 Oral
- 1.4.3 Subcutaneous
- 1.4.4 Intramuscular
- 1.4.5 Others
- 1.5 Market by Application
- 1.5.1 Global Animal Biological Vaccine Market Size Growth Rate by Application
- 1.5.2 Porcine
- 1.5.3 Poultry
- 1.5.4 Livestock
- 1.5.5 Companion Animals
- 1.5.6 Aquaculture
- 1.6 Coronavirus Disease 2019 (Covid-19): Animal Biological Vaccine Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Animal Biological Vaccine Industry
- 1.6.1.1 Animal Biological Vaccine Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Animal Biological Vaccine Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Animal Biological Vaccine Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Animal Biological Vaccine Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Animal Biological Vaccine Market Size Estimates and Forecasts
- 2.1.1 Global Animal Biological Vaccine Revenue 2015-2026
- 2.1.2 Global Animal Biological Vaccine Sales 2015-2026
- 2.2 Animal Biological Vaccine Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Animal Biological Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Animal Biological Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Animal Biological Vaccine Competitor Landscape by Players
- 3.1 Animal Biological Vaccine Sales by Manufacturers
- 3.1.1 Animal Biological Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 Animal Biological Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Animal Biological Vaccine Revenue by Manufacturers
- 3.2.1 Animal Biological Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 Animal Biological Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Animal Biological Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Animal Biological Vaccine Revenue in 2019
- 3.2.5 Global Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Animal Biological Vaccine Price by Manufacturers
- 3.4 Animal Biological Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Animal Biological Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Animal Biological Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Animal Biological Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Animal Biological Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global Animal Biological Vaccine Sales by Type (2015-2020)
- 4.1.2 Global Animal Biological Vaccine Revenue by Type (2015-2020)
- 4.1.3 Animal Biological Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Animal Biological Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Animal Biological Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Animal Biological Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 Animal Biological Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Animal Biological Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Animal Biological Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global Animal Biological Vaccine Sales by Application (2015-2020)
- 5.1.2 Global Animal Biological Vaccine Revenue by Application (2015-2020)
- 5.1.3 Animal Biological Vaccine Price by Application (2015-2020)
- 5.2 Animal Biological Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Animal Biological Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Animal Biological Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Animal Biological Vaccine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Animal Biological Vaccine by Country
- 6.1.1 North America Animal Biological Vaccine Sales by Country
- 6.1.2 North America Animal Biological Vaccine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Animal Biological Vaccine Market Facts & Figures by Type
- 6.3 North America Animal Biological Vaccine Market Facts & Figures by Application
7 Europe
- 7.1 Europe Animal Biological Vaccine by Country
- 7.1.1 Europe Animal Biological Vaccine Sales by Country
- 7.1.2 Europe Animal Biological Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Animal Biological Vaccine Market Facts & Figures by Type
- 7.3 Europe Animal Biological Vaccine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Animal Biological Vaccine by Region
- 8.1.1 Asia Pacific Animal Biological Vaccine Sales by Region
- 8.1.2 Asia Pacific Animal Biological Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Animal Biological Vaccine Market Facts & Figures by Type
- 8.3 Asia Pacific Animal Biological Vaccine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Animal Biological Vaccine by Country
- 9.1.1 Latin America Animal Biological Vaccine Sales by Country
- 9.1.2 Latin America Animal Biological Vaccine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Animal Biological Vaccine Market Facts & Figures by Type
- 9.3 Central & South America Animal Biological Vaccine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Animal Biological Vaccine by Country
- 10.1.1 Middle East and Africa Animal Biological Vaccine Sales by Country
- 10.1.2 Middle East and Africa Animal Biological Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Animal Biological Vaccine Market Facts & Figures by Type
- 10.3 Middle East and Africa Animal Biological Vaccine Market Facts & Figures by Application
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description, Business Overview and Total Revenue
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Animal Biological Vaccine Products Offered
- 11.1.5 Merck Recent Development
- 11.2 Zoetis
- 11.2.1 Zoetis Corporation Information
- 11.2.2 Zoetis Description, Business Overview and Total Revenue
- 11.2.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Zoetis Animal Biological Vaccine Products Offered
- 11.2.5 Zoetis Recent Development
- 11.3 Merial/Sanofi
- 11.3.1 Merial/Sanofi Corporation Information
- 11.3.2 Merial/Sanofi Description, Business Overview and Total Revenue
- 11.3.3 Merial/Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Merial/Sanofi Animal Biological Vaccine Products Offered
- 11.3.5 Merial/Sanofi Recent Development
- 11.4 Boehringer Ingelheim
- 11.4.1 Boehringer Ingelheim Corporation Information
- 11.4.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
- 11.4.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Boehringer Ingelheim Animal Biological Vaccine Products Offered
- 11.4.5 Boehringer Ingelheim Recent Development
- 11.5 Ceva
- 11.5.1 Ceva Corporation Information
- 11.5.2 Ceva Description, Business Overview and Total Revenue
- 11.5.3 Ceva Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Ceva Animal Biological Vaccine Products Offered
- 11.5.5 Ceva Recent Development
- 11.6 CAHIC
- 11.6.1 CAHIC Corporation Information
- 11.6.2 CAHIC Description, Business Overview and Total Revenue
- 11.6.3 CAHIC Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 CAHIC Animal Biological Vaccine Products Offered
- 11.6.5 CAHIC Recent Development
- 11.7 HVRI
- 11.7.1 HVRI Corporation Information
- 11.7.2 HVRI Description, Business Overview and Total Revenue
- 11.7.3 HVRI Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 HVRI Animal Biological Vaccine Products Offered
- 11.7.5 HVRI Recent Development
- 11.8 Ringpu Biology
- 11.8.1 Ringpu Biology Corporation Information
- 11.8.2 Ringpu Biology Description, Business Overview and Total Revenue
- 11.8.3 Ringpu Biology Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Ringpu Biology Animal Biological Vaccine Products Offered
- 11.8.5 Ringpu Biology Recent Development
- 11.9 Yebio
- 11.9.1 Yebio Corporation Information
- 11.9.2 Yebio Description, Business Overview and Total Revenue
- 11.9.3 Yebio Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Yebio Animal Biological Vaccine Products Offered
- 11.9.5 Yebio Recent Development
- 11.10 DHN
- 11.10.1 DHN Corporation Information
- 11.10.2 DHN Description, Business Overview and Total Revenue
- 11.10.3 DHN Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 DHN Animal Biological Vaccine Products Offered
- 11.10.5 DHN Recent Development
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description, Business Overview and Total Revenue
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Animal Biological Vaccine Products Offered
- 11.1.5 Merck Recent Development
- 11.12 Elanco/Eli Lilly
- 11.12.1 Elanco/Eli Lilly Corporation Information
- 11.12.2 Elanco/Eli Lilly Description, Business Overview and Total Revenue
- 11.12.3 Elanco/Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Elanco/Eli Lilly Products Offered
- 11.12.5 Elanco/Eli Lilly Recent Development
- 11.13 Virbac
- 11.13.1 Virbac Corporation Information
- 11.13.2 Virbac Description, Business Overview and Total Revenue
- 11.13.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Virbac Products Offered
- 11.13.5 Virbac Recent Development
- 11.14 Jinyu Bio-Technology
- 11.14.1 Jinyu Bio-Technology Corporation Information
- 11.14.2 Jinyu Bio-Technology Description, Business Overview and Total Revenue
- 11.14.3 Jinyu Bio-Technology Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Jinyu Bio-Technology Products Offered
- 11.14.5 Jinyu Bio-Technology Recent Development
- 11.15 ChengDu Tecbond
- 11.15.1 ChengDu Tecbond Corporation Information
- 11.15.2 ChengDu Tecbond Description, Business Overview and Total Revenue
- 11.15.3 ChengDu Tecbond Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 ChengDu Tecbond Products Offered
- 11.15.5 ChengDu Tecbond Recent Development
- 11.16 CAVAC
- 11.16.1 CAVAC Corporation Information
- 11.16.2 CAVAC Description, Business Overview and Total Revenue
- 11.16.3 CAVAC Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 CAVAC Products Offered
- 11.16.5 CAVAC Recent Development
- 11.17 Kyoto Biken
- 11.17.1 Kyoto Biken Corporation Information
- 11.17.2 Kyoto Biken Description, Business Overview and Total Revenue
- 11.17.3 Kyoto Biken Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Kyoto Biken Products Offered
- 11.17.5 Kyoto Biken Recent Development
- 11.18 FATRO
- 11.18.1 FATRO Corporation Information
- 11.18.2 FATRO Description, Business Overview and Total Revenue
- 11.18.3 FATRO Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 FATRO Products Offered
- 11.18.5 FATRO Recent Development
- 11.19 Vaksindo
- 11.19.1 Vaksindo Corporation Information
- 11.19.2 Vaksindo Description, Business Overview and Total Revenue
- 11.19.3 Vaksindo Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Vaksindo Products Offered
- 11.19.5 Vaksindo Recent Development
- 11.20 Bio-Labs
- 11.20.1 Bio-Labs Corporation Information
- 11.20.2 Bio-Labs Description, Business Overview and Total Revenue
- 11.20.3 Bio-Labs Sales, Revenue and Gross Margin (2015-2020)
- 11.20.4 Bio-Labs Products Offered
- 11.20.5 Bio-Labs Recent Development
- 11.21 Avimex Animal
- 11.21.1 Avimex Animal Corporation Information
- 11.21.2 Avimex Animal Description, Business Overview and Total Revenue
- 11.21.3 Avimex Animal Sales, Revenue and Gross Margin (2015-2020)
- 11.21.4 Avimex Animal Products Offered
- 11.21.5 Avimex Animal Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Animal Biological Vaccine Market Estimates and Projections by Region
- 12.1.1 Global Animal Biological Vaccine Sales Forecast by Regions 2021-2026
- 12.1.2 Global Animal Biological Vaccine Revenue Forecast by Regions 2021-2026
- 12.2 North America Animal Biological Vaccine Market Size Forecast (2021-2026)
- 12.2.1 North America: Animal Biological Vaccine Sales Forecast (2021-2026)
- 12.2.2 North America: Animal Biological Vaccine Revenue Forecast (2021-2026)
- 12.2.3 North America: Animal Biological Vaccine Market Size Forecast by Country (2021-2026)
- 12.3 Europe Animal Biological Vaccine Market Size Forecast (2021-2026)
- 12.3.1 Europe: Animal Biological Vaccine Sales Forecast (2021-2026)
- 12.3.2 Europe: Animal Biological Vaccine Revenue Forecast (2021-2026)
- 12.3.3 Europe: Animal Biological Vaccine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Animal Biological Vaccine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Animal Biological Vaccine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Animal Biological Vaccine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Animal Biological Vaccine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Animal Biological Vaccine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Animal Biological Vaccine Sales Forecast (2021-2026)
- 12.5.2 Latin America: Animal Biological Vaccine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Animal Biological Vaccine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Animal Biological Vaccine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Animal Biological Vaccine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Animal Biological Vaccine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Animal Biological Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Animal Biological Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Animal Biological Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Animal Biological Vaccine. Industry analysis & Market Report on COVID-19 Impact on Global Animal Biological Vaccine is a syndicated market report, published as COVID-19 Impact on Global Animal Biological Vaccine Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Animal Biological Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
